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We evaluated the invasiveness of breast approach endoscopic thyroidectomy (BAET) carried out by surgeon very experienced in
this procedure. Twenty-four patients who underwent BAET and 19 patients who underwent conventional thyroidectomy were the
study population. Postoperative pain was assessed by a visual analog scale (VAS). The values 2, 12, and 24h after surgery were
signiﬁcantly lower in the BAET group than those in the conventional group. Serum IL-6 and CRP levels were measured by an
ELISA preoperatively and at 2, 12, 24 and 48h after operation. Their values increased signiﬁcantly after both procedures when
compared to preoperative levels with signiﬁcant diﬀerences between the two groups detected at the 24-hour and 48-hour time
points. Subjective and objective evidence supported the notion that BAET could become a minimally invasive procedure if the
surgeon gained suﬃcient experience.
1.Introduction
Pursuit of an esthetically pleasing scar after open thyroidec-
tomy has led surgeons to carry out endoscopic thyroid
surgery [1]. H¨ uscher et al. [2] described the ﬁrst case
in 1997. Ikeda et al. [3] and Ohgami et al. [4] further
improved the cosmetic result by carrying out endoscopic
thyroidectomyviaanaxillaryandanteriorbreastapproachin
2000. This scarless (in the neck) endoscopic thyroidectomy
(SET) attracted widespread attention due to the very good
cosmetic eﬀect achieved. The disadvantage of SET is a
much larger plane of tissue dissection [1, 5]. Some surgeons
think that SET should be classiﬁed as “minimal access but
maximally invasive” surgery [1].
SET is usually related to longer operation time and
more postoperative pain [1, 5], but some surgeons believe
that these factors could reduced with the accumulation of
experience [1, 6]. The learning curve of SET is very long, and
a surgeon has to carry out about 150 SETs before reaching an
advanced level in terms of the skill, proﬁciency, and stability
of the operation [7].
Until August 2006, >230 cases of SET (all were breast
approach endoscopic thyroidectomy (BAET)) have been
carried out in our center. We believe that evaluating the
invasivenessofthisinnovativesurgicalprocedureatthisstage
is rational.
Current evaluation of surgical invasiveness related to
SET relies solely on assessment of postoperative pain, so
subjective bias cannot be avoided [8, 9]. Surgery is a unique
example of “planned trauma” not only leading to pain,
but also evoking a metabolic and inﬂammatory response
(acute-phase response) characterized by release of various
proinﬂammatory cytokines and increased production of
acute-phase proteins [10]. Interleukin-6 (IL-6) and C-
reactive protein (CRP) are valuable indicators reﬂecting the
inﬂammatory and acute phase response after laparoscopic
surgery [11–13] .T h eg o a lo ft h i sr e s e a r c hw a st oe v a l u a t e
the invasiveness of BAET, carried out by a very experienced
surgeon, with subjective and objective indicators.
2. Patients andMethods
2.1. Ethical Approval of the Study Protocol. All patients were
informed about the study protocol. Signed written consent
fortheinvestigationinaccordancewiththeethicalguidelines
of Changzheng Hospital was obtained.2 Clinical and Developmental Immunology
Table 1: Clinical data of the patients.
Endoscopic group Conventional group P-value
Age (y) 39.00 ±9.17 48.26 ±10.47 .003
Tumor size in ultrasound (mm) 23.25 ±8.84 27.78 ±9.06 .056
Operation duration (min) 88.04 ±28.73 90.05 ±18.40 .793
Blood loss (ml) 17.88 ±5.32 49.32 ±10.93 .000
Length of incision (cm) 2.90 ±0.28 6.16 ±0.76 .000
Pathology (adenoma/nodular goiter) 23/1 17/2 .446
2.2. Patients. A prospective nonrandomized comparative
study was conducted between September 2006 and May
2007. Enrolled in this research were 43 consecutive patients
diagnosed with benign thyroid nodules. Surgical procedure
(BAET or open thyroidectomy) was determined according to
the wishes of the patient. Twenty-four patients (22 females
and 2 males; mean age, 39.00 ± 9.17 years) who received
BAET were assigned to the “endoscopic group”, and the
remaining 19 patients (13 females and 6 males; mean age,
48.26±10.47years)receivedconventionalthyroidectomyand
were assigned to the “conventional group”. Exclusion criteria
were a history of neck surgery or radiotherapy, thyroiditis
diagnosed by preoperative biochemistry or ultrasonography,
liver dysfunction, and immune system diseases.
2.3. Thyroidectomy. The endoscopic surgical procedure is
described elsewhere [7]. BAET was carried out by one
surgeon (Ming Qiu). Brieﬂy, BAET was done under general
anesthesia with the patient being in the supine position.
A 12–15mm curved longitudinal incision was placed along
the medial contour of the right breast for the camera port,
and two 5mm incisions were made in the circumareolar
region for the working ports. A working space was created
with application of a harmonic scalpel under endoscopic
guidance. The dissection plane was strictly over the muscular
fascia. The lesion was exposed after the cervical linea alba
was divided longitudinally. Partial, subtotal, near-total or
total lobectomy was done according to lesion characteristics
[14].
Conventional thyroidectomy was done through a 6cm
transverse cervical incision. Subplatysmal ﬂaps were freed
superiorly to the thyroid cartilage and inferiorly to the
suprasternal notch. Then the lesion was exposed, and
thyroidectomy was carried out.
2.4. Subjective Assessment of Postoperative Pain. Postoper-
ative pain was assessed by a visual analog scale (VAS)
consisting of a 10cm line with the words “no pain” on the
left side as “0” and “worst pain imaginable” on the right side
as “10” [15]. All patients were asked to report their pain 2,
12, 24, and 48h after surgery using the VAS.
2.5. Preparation of Blood Samples and Assays. Blood samples
were obtained three days before surgery and 2, 12, 24,
and 48h after surgery. They were centrifuged at 1,250×g
for 15min to separate the serum and stored at −70
◦C
u n t i la s s a y .T h eI L - 6c o n c e n t r a t i o nw a sm e a s u r e dw i t ha n
enzyme-linked immunosorbent assay (ELISA) kit (R&D
Systems, Minneapolis, MN, USA) according to manufac-
turer’s instructions. Brieﬂy, the system used a solid-phase
monoclonal antibody and an enzyme-linked polyclonal
antibody against human IL-6. All analyses and calibrations
were done in duplicate using 100μL serum for each analysis.
Absorbance was determined at 450nm. CRP concentration
was measured automatically by nephelometry (BN II, Dade
Behring, Marburg, Germany) according to manufacturer’s
instructions. The sensitivity was 0.7pg/mL for IL-6 and
0.175mg/L for CRP.
2.6. Statistical Analyses. Patient age, tumor size, incision
length, blood loss, duration of surgery, and postoperative
pain score were expressed as means ± SEM. Diﬀerences
in these parameters between the two groups were ana-
lyzed by Student’s t-test. Diﬀerences in pathologic ﬁndings
(adenoma/nodular goiter) between the two groups were
analyzed by χ2 test. Diﬀerences in the change in the level
of IL-6 and CRP between the two groups were analyzed by
nonparametric test. Probability was determined using two-
sided statistical tests. P<. 05 was considered signiﬁcant.
3. Results
3.1. Surgical Outcomes. The mean age of patients in the
endoscopic group was signiﬁcantly younger than that of
the conventional group. There was no signiﬁcant diﬀerence
between the two groups with respect to tumor size, duration
of surgery,and pathological type oflesions. The composition
of diﬀerent surgical procedures (partial/sub-near total/total)
did not reach signiﬁcant level between groups (2/13/9 versus
3/7/9, P = .487).The volume of blood loss and the length of
incision were signiﬁcantly reduced in the endoscopic group
compared with the conventional group (Table 1).
Complications such as recurrent laryngeal nerve (RLN)
palsy, hypocalcemia, hypercapnia, subcutaneous emphy-
sema, and seroma were not observed in either group.
3.2. Postoperative Pain. Postoperative pain began to increase
2h after the end of surgery, reached a peak 12h after surgery,
and decreased gradually in both groups (Table 2). According
to the VAS, pain severity on the ﬁrst day of surgery in the
conventional group was signiﬁcantly higher than that in theClinical and Developmental Immunology 3
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Figure 1: Time course of serum IL-6 and CRP levels among conventional and endoscopic groups before and after operation.
Table 2: VAS after thyroidectomy.
Endoscopic group Conventional group P-value
2hafteroperation 2.92 ±0.50 3.78 ±1.02 .00
12h after operation 2.93 ±0.81 5.42 ±0.85 .00
24h after operation 1.15 ±0.44 2.03 ±0.61 .00
48h after operation 0.28 ±0.41 0.43 ±0.51 .31
All data are expressed in mean ±SD.
endoscopic group and was not signiﬁcant 48h after surgery
in both groups.
3.3.ChangeinSerumLevelsofIL-6andCRP. Theserumlevel
o fI L - 6a n dC R Po v e rt i m ei sd e p i c t e di nT a b l e3. There was
no signiﬁcant diﬀerence in the baseline level of IL-6 and CRP
between the groups (P>. 05). Signiﬁcant elevation of IL-6
was induced by endoscopic thyroidectomy and conventional
thyroidectomy, reaching a summit 24h after surgery whereas
the CRP level increased later than did IL-6 and continued
to increase even 48h after surgery. Relatively slower and
lower elevation of IL-6 and CRP levels was observed in the
endoscopic group compared with that in the conventional
group. There was no signiﬁcant diﬀerence in the change of
IL-6 and CRP levels 2h and 12h after surgery between the
two groups, but they reached a signiﬁcant level 24h and 48h
after surgery (Table 3, Figure 1).
4. Discussion
Conventional thyroidectomy is a safe, eﬀective, and well-
tolerated method for treating various thyroid diseases. SET is
aninnovativeprocedurewithextremelysatisfactorycosmetic
results, but we do not wish to assess the level of invasiveness
of SET because many surgeons consider it to be a very
technically challenging procedure [7–9]. We carried out this
research only after we had reached an advanced stage of
proﬁciency (carried out >230 cases) [7].
Minimally invasive surgery can be deﬁned as the ability
of the surgeon to carry out traditional surgical procedures in
novelwaystominimize thetraumaofsurgicalexposure[16].
IL-6 and CRP are the markers of the acute inﬂammatory
response, and indicate the degree of surgical invasiveness
[11, 17, 18]. Trends in the evolution of IL-6 and CRP
over time in the present study were similar to those after
abdominal surgery [11, 17], but the levels were lower.
This supported the notion that thyroidectomy is not as
extreme as abdominal surgery with respect to invasiveness
[6]. As there was no signiﬁcant diﬀerence between groups in
composition of surgical procedures, the possibility of more
invasiveness originated from more invasive procedure was
ruled out. Based on our subjective and objective evidence,
we concluded that BAET could be a minimally invasive
approach for treating benign thyroid diseases.
Our initial experience showed that the operation time
of BAET was signiﬁcantly longer than that of open thy-
roidectomy [19],butsomeauthorsbelievethattheoperation4 Clinical and Developmental Immunology
Table 3: Variation of serum IL-6 (pg/ml) and CRP (mg/L) levels after operation.
Endoscopic group Conventional group P-value
IL-6
Before operation 1.65 (0.99–2.80) 2.66 (1.58–3.60)
2h after operation 4.31 (2.47–6.43)
∗ 5.21 (2.66–10.40)
∗ .420
12h after operation 4.98 (3.37–8.11)
∗ 8.53 (4.70–13.32)
∗ .085
24h after operation 5.42 (2.95–8.39)
∗ 12.2 (8.44–26.81)
∗ .003
48h after operation 4.32 (3.14–10.87)
∗ 9.21 (4.62–17.99)
∗ .042
CRP
Before operation 3.19 (3.10–3.19) 3.21 (3.00–3.28)
2h after operation 3.22 (3.08–3.30) 3.24 (3.11–3.33) .949
12h after operation 3.25 (3.20–4.41) 3.28 (3.00–4.51) .851
24h after operation 5.07 (3.19–8.03)
∗ 11.10 (3.64–22.10)
∗ .030
48h after operation 5.92 (3.19–13.90)
∗ 27.60 (15.60–66.00)
∗∗
.001
All data are expressed in median (P25–P75).
The diﬀerence in serum IL-6 and CRP levels between the two groups was analyzed with Wilcoxon rank sum test.
∗P<. 05, comparing with the preoperative value. The diﬀerence in postoperative serum IL-6 and CRP levels in both groups was analyzed with Friedman M
test and q test.
time could be reduced [1, 20]. Study of the learning curve
conﬁrmed that the operation time was signiﬁcantly reduced
and that the proﬁciency and stability of the operation
reached an advanced level after the surgeon completed
>150 cases of endoscopic thyroidectomy [7]. There was no
signiﬁcant diﬀerence in the duration of surgery between the
two groups in the present study.
The dissection area in the anterior breast and neck is
signiﬁcantly larger than that of conventional surgery (data
not shown), but does a large area of tissue dissection nec-
essarily mean macroinvasiveness? The concept of endoscopic
subcutaneoussurgeryhadbeenintroducedbefore,anditwas
also conﬁrmed in animal models that dissection in this plane
causes less trauma to the overlying and dissected tissues [21].
From an anatomic point of view, there is a potential space
(the“fasciacleft”)betweenadistinctdeepmembranouslayer
of the superﬁcial fascia and muscular fascia in the neck and
the anterior breast region [22]. A working space was created
along this layer in our series. We hypothesized that as long
as the dissection was in the right surgical plane, invasiveness
willnotnecessarilyincreasesigniﬁcantlyeventhoughthedis-
sectionareaisrelativelylarger.Thiswasconﬁrmedbyastudy
by Wang showing that endoscopic thyroidectomy neither
enhanced the inﬂammatory response nor damaged human
function despite extensive dissection of skin ﬂaps [23].
The reduced invasiveness of BAET could be attributed
to its advantages over open surgery. The mean total length
of the three incisions was only 2.9cm in the current study.
The shorter a single incision, the lesser disturbance to the
integrity of anatomic structure it brought. In addition,
endoscopic ampliﬁcation of the visual ﬁeld and the use of
a harmonic scalpel enabled the resection to be more accurate
and reduce the volume of hemorrhage [5, 20, 24]. Blood
loss in the endoscopic group was signiﬁcantly lower than
that in the conventional group. The length of incision and
total blood loss are important factors aﬀecting surgical stress
[25–27], so there is good reason to assume that BAET is
advantageous over conventional thyroidectomy in reducing
surgical trauma.
5. Conclusion
The present study demonstrated that BAET could be a
minimally invasive procedure in expert hands. Attributable
factors are shortened total length of incisions and reduced
volume of blood loss. With accumulation of experience, the
duration of surgery could be reduced to the level comparable
with open surgery, and the invasiveness would not be
enhanced despite the larger area of tissue dissection.
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